Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

22.01 +0.05 (+0.23%)
Streaming Delayed Price Updated: 11:40 AM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 796,806
Open 21.90
Bid (Size) 22.01 (2)
Ask (Size) 22.02 (2)
Prev. Close 21.96
Today's Range 21.55 - 22.33
52wk Range 2.020 - 25.72
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Viking Therapeutics Stock Is Heating Up Today
Positive analyst coverage is fueling another uptick in the biotech's stock today. 
Via The Motley Fool
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
Recent moves to the upside could be the beginning of a much larger bull run. 
Via The Motley Fool

Performance

YTD
+158.34%
+158.34%
1 Month
-0.50%
-0.50%
3 Month
+93.24%
+93.24%
6 Month
+443.46%
+443.46%
1 Year
+891.45%
+891.45%

More News

Read More
3 Biotech Stocks Sitting on Huge-Upside Catalysts
Via InvestorPlace
Viking Therapeutics Inc. (NASDAQ: VKTX) is a Stock Spotlight on 5/23
Via Investor Brand Network
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Viking Therapeutics Stock Is Buckling Today
Via The Motley Fool
What 17 Analyst Ratings Have To Say About Viking Therapeutics
Via Benzinga
Why Viking Therapeutics Stock Bolted Higher Today
Via The Motley Fool
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Via Investor's Business Daily
Intercept Crashes As FDA Advisors Deliver The Likely Deathblow For Its Highly Watched NASH Drug
Via Investor's Business Daily
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
Via InvestorPlace
7 Stocks That Wall Street Analysts Are Loving in May
Via InvestorPlace
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
Via Benzinga
Why Viking Therapeutics Stock Wobbled Today
Via The Motley Fool
Why Viking Therapeutics Stock Briefly Popped Today
Via The Motley Fool
Expert Ratings for Viking Therapeutics
Via Benzinga
Earnings Preview For Viking Therapeutics
Via Benzinga
Is Novo Nordisk Stock a Screaming Buy Right Now?
Via The Motley Fool
Why Top 1% Biotech Viking Therapeutics Is At The Brink Of A Record High
Via Investor's Business Daily
Why Viking Therapeutics Stock Is Trading Higher Tuesday
Via Benzinga
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
Via The Motley Fool
Eli Lilly's Diabetes Newcomer, Mounjaro, Just Blew Sales Projections Out Of The Water
Via Investor's Business Daily
Earnings Scheduled For April 26, 2023
Via Benzinga
3 Top Biotech Stocks Defying the Bear Market
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.